Scortis Pharma Limited
About Scortis Pharma Limited
Data last updated:
Scortis Pharma Limited is a public limited company based in C, Rajasthan, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 23 March 1998 and has been in existence for over 28 years.
The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U24232RJ1998PLC014717. Its GSTIN is 08AAECS7859N1ZG (Rajasthan).
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹15 Lakh. It is led by directors including Aniruddh Modi and Anjali Modi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 48 Shivaji Nagar Civil Lines Jaipur., Rajasthan, India.
As per the financials filed for FY 2025, the company reported a revenue of ₹59.59 Lakh, a decline of 8% compared to the previous year. For the same year it recorded a net profit of ₹1.6 Lakh (net margin 2.7%) and EBITDA of ₹2.91 Lakh (EBITDA margin 4.9%). Revenue has declined at a compounded annual rate (CAGR) of 7% over three years.
As per MCA filings, the company has satisfied charges of ₹32 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social Media
- Registered Address48 Shivaji Nagar Civil Lines Jaipur., Rajasthan, India
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Scortis Pharma Limited
The main business activity of Scortis Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Scortis Pharma Limited
Scortis Pharma Limited is audited by SANJAY PRAMOD & ASSOCIATES for the financial year 2019.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| SANJAY PRAMOD & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Scortis Pharma Limited
Scortis Pharma has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Aniruddh Modi | Director | 06 Jul 2019 | 7 Years 2 Months | Current |
| Anjali Modi | Director | 30 May 2000 | 26 Years 4 Months | Current |
| Ashish Modi | Director | 30 Mar 1998 | 28 Years 6 Months | Current |
Financials of Scortis Pharma Limited FY 2025 filings available
Scortis Pharma Limited reported revenue of ₹59.59 Lakh (down 8% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Scortis Pharma Limited
Revenue has declined at a compounded annual rate (CAGR) of 7% over three years, including a 8% fall in the latest year. EBITDA fell 2% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Scortis Pharma Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹2.91 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.6 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Scortis Pharma Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.9% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 2.7% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Scortis Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Scortis Pharma Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Scortis Pharma Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 12 Feb 2016 | Kotak Mahindra Prime Limited | ₹17 Lakh | Satisfied |
| 23 May 2005 | Bank of Baroda | ₹15 Lakh | Satisfied |
Total charge records: 2 View all charges
Employees and EPFO Compliance at Scortis Pharma Limited
Employment history and EPFO contributions of people linked to Scortis Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Scortis Pharma Limited
Scortis Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 08AAECS7859N1ZG | Rajasthan | Active | 26 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Scortis Pharma Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Scortis Pharma Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Scortis Pharma Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Scortis Pharma Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Scortis Pharma Limited
Frequently Asked Questions about Scortis Pharma Limited
Scortis Pharma is an active public limited company based in C, Rajasthan, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 23 March 1998 (28+ years old) and is registered under CIN U24232RJ1998PLC014717.
Scortis Pharma reported revenue of ₹59.59 Lakh for FY 2025 (down 8% YoY).
Scortis Pharma has 3 current directors:
- Aniruddh Modi - Director
- Anjali Modi - Director
- Ashish Modi - Director
Scortis Pharma reported a net profit of ₹1.6 Lakh (net margin 2.7%) and EBITDA of ₹2.91 Lakh (EBITDA margin 4.9%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Scortis Pharma is -7% over three years. In the latest year (FY 2025) revenue fell 8%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Scortis Pharma is 08AAECS7859N1ZG, registered in Rajasthan.
The CIN (Corporate Identification Number) of Scortis Pharma is U24232RJ1998PLC014717. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Scortis Pharma was incorporated on 23 March 1998, making it 28+ years old. It is registered with the Registrar of Companies, Jaipur.
The registered office of Scortis Pharma is at 48 Shivaji Nagar Civil Lines Jaipur., Rajasthan, India.